A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer

A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer is a phase 2/3, randomised interventional study registered as NCT07711067 by ElmediX, with a registry enrolment figure of 95 participants, started 2026-10-01 and due to reach its primary completion in 2030-03-31. Interventions recorded: Whole-body hyperthermia; Standard-of-Care Systemic therapy. Conditions listed: Pancreatic Ductal Adenocarcinoma (mPDAC); Metastatic Pancreatic Ductal Adenocarcinoma (PDAC). Primary outcome: Overall survival (OS); Safety and tolerability of WBHT + SoC and SoC alone. Pancreatic eligibility wording from the registry: "Subjects with metastatic pancreatic adenocarcinoma (PDAC) confirmed by histology". Sites: Belgium, Spain. No results are recorded here; the registry entry is the source.